Rebecca Burrell

Ms. Rebecca Burrell

Child and Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2022 in Clinical Immunology
Verified
Journal Article
Open access
WKWeng Hua Khoo
Weng Hua Khoo
KJKatherine Jackson
Katherine Jackson
CPChansavath Phetsouphanh
Chansavath Phetsouphanh
JZJohn J. Zaunders
John J. Zaunders
JAJosé Alquicira-Hernandez
José Alquicira-Hernandez
TPTri Giang Phan
Tri Giang Phan
Children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) develop less severe coronavirus disease 2019 (COVID-19) than adults. The mechanisms for the age-specific differences and the implications for infection-induced immunity are beginning to be uncovered. We show by longitudinal multimodal analysis that SARS-CoV-2 leaves a small footprint in the circulating T cell compartment in children with mild/asymptomatic COVID-19 compared to adult household contacts with the same disease severity who had more evidence of systemic T cell interferon activation, cytotoxicity and exhaustion. Children harbored diverse polyclonal SARS-CoV-2-specific naïve T cells whereas adults harbored clonally expanded SARS-CoV-2-specific memory T cells. A novel population of naïve interferon-activated T cells is expanded in acute COVID-19 and is recruited into the memory compartment during convalescence in adults but not children. This was associated with the development of robust CD4+ memory T cell responses in adults but not children. These data suggest that rapid clearance of SARS-CoV-2 in children may compromise their cellular immunity and ability to resist reinfection.

1 July 2018 in Virus Evolution
Verified
Journal Article
Open access
PDF file
JCJoanna C A Cobbin
Joanna C A Cobbin
PBPhilip N Britton
Philip N Britton
RBRebecca Burrell
Rebecca Burrell
DTDeepali Thosar
Deepali Thosar
KSKierrtana Selvakumar
Kierrtana Selvakumar
EHEdward Holmes
Edward Holmes
Human enteroviruses (EV) pose a major risk to public health. This is especially so in the Asia-Pacific region where increasing numbers of hand, foot and mouth disease (HFMD) cases and large outbreaks of severe neurological disease associated with EV-A71 have occurred. Despite their importance, key aspects of the emergence, epidemiology and evolution of EVs remain unclear, and most studies of EV evolution have focused on a limited number of genes. Here, we describe the genomic-scale evolution of EV-A viruses sampled from pediatric patients with mild disease attending a single hospital in western Sydney, Australia, over an 18-month period. This analysis revealed the presence of eight viral serotypes—Coxsackievirus (CV) A2, A4, A5, A6, A8, A10, A16 and EV-A71—with up to four different serotypes circulating in any 1 month. Despite an absence of large-scale outbreaks, high levels of geographical and temporal mixing of serotypes were identified. Phylogenetic analysis revealed that multiple strains of the same serotype were present in the community, and that this diversity was shaped by multiple introductions into the Sydney population, with only a single lineage of CV-A6 exhibiting in situ transmission over the entire study period. Genomic-scale analyses also revealed the presence of novel and historical EV recombinants. Notably, our analysis revealed no association between viral phylogeny, including serotype, and patient age, sex, nor disease severity (for uncomplicated disease). This study emphasizes the contribution of EV-A viruses other than EV-A71 to mild EV disease including HFMD in Australia and highlights the need for greater surveillance of these viruses to improve strategies for outbreak preparedness and vaccine design.

1 April 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PBPhilip N. Britton
Philip N. Britton
KWKaren Walker
Karen Walker
BMBrendan McMullan
Brendan McMullan
CGClaire Galea
Claire Galea
RBRebecca Burrell
Rebecca Burrell
CJCheryl A. Jones
Cheryl A. Jones

22 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RBRebecca Burrell
Rebecca Burrell
GSGemma L. Saravanos
Gemma L. Saravanos
AKAlison Kesson
Alison Kesson
KLKin-Chuen Leung
Kin-Chuen Leung
AOAlex C. Outhred
Alex C. Outhred
PBPhilip N. Britton
Philip N. Britton
Acute respiratory infections cause significant paediatric morbidity, but for pathogens other than influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, systematic monitoring is not commonly performed. This retrospective analysis of six years of routinely collected respiratory pathogen multiplex PCR testing at a major paediatric hospital in New South Wales Australia, describes the epidemiology, year-round seasonality, and co-detection patterns of 15 viral respiratory pathogens. 32,599 respiratory samples from children aged under 16 years were analysed. Most samples were associated with a hospital admission (24,149, 74.1%) and the median age of sampling was 16 months (IQR 5–53). Viruses were detected in 62.9% (20,510) of samples, with single virus detections occurring in 73.5% (15,082) of positive samples. In instances of single virus detection, rhinovirus was most frequent (5125, 40.6%), followed by RSV-B (1394, 9.2%) and RSV-A (1290, 8.6%). Moderate to strong seasonal strength was observed for most viruses with some notable exceptions. Rhinovirus and enterovirus were detected year-round and low seasonal strength was observed for adenovirus and bocavirus. Biennial seasonal patterns were observed for influenza B and parainfluenza virus 2. Co-detections occurred in 5,428 samples, predominantly with two (4284, 79.0%) or three viruses (904, 16.7%). The most common co-detections were rhinovirus-adenovirus (566, 10.4%), rhinovirus-enterovirus (357, 8.3%), and rhinovirus-RSV-B (337, 7.9%). Ongoing pan-pathogen surveillance, integrating both laboratory and clinical data, is necessary to assist in identification of key pathogens and combination of pathogens to support effective preventative public health strategies and reduce the burden of paediatric respiratory infections.

21 June 2022 in Pathology
Verified
Journal Article
Closed access
TGT. Gulholm
T. Gulholm
MYM. Yeang
M. Yeang
INI. Nguyen
I. Nguyen
PAP.I. Andrews
P.I. Andrews
RBR. Balgahom
R. Balgahom
WRW. Rawlinson
W. Rawlinson

19 April 2023 in Viruses
Verified
Journal Article
Open access
PDF file
RTRachel Tulloch
Rachel Tulloch
KKKaran Kim
Karan Kim
CSChisha Sikazwe
Chisha Sikazwe
AMAlice Michie
Alice Michie
RBRebecca Burrell
Rebecca Burrell
JEJohn-Sebastian Eden
John-Sebastian Eden
Emerging infectious disease threats require rapid response tools to inform diagnostics, treatment, and outbreak control. RNA-based metagenomics offers this; however, most approaches are time-consuming and laborious. Here, we present a simple and fast protocol, the RAPIDprep assay, with the aim of providing a cause-agnostic laboratory diagnosis of infection within 24 h of sample collection by sequencing ribosomal RNA-depleted total RNA. The method is based on the synthesis and amplification of double-stranded cDNA followed by short-read sequencing, with minimal handling and clean-up steps to improve processing time. The approach was optimized and applied to a range of clinical respiratory samples to demonstrate diagnostic and quantitative performance. Our results showed robust depletion of both human and microbial rRNA, and library amplification across different sample types, qualities, and extraction kits using a single workflow without input nucleic-acid quantification or quality assessment. Furthermore, we demonstrated the genomic yield of both known and undiagnosed pathogens with complete genomes recovered in most cases to inform molecular epidemiological investigations and vaccine design. The RAPIDprep assay is a simple and effective tool, and representative of an important shift toward the integration of modern genomic techniques with infectious disease investigations.